Carcinogen metabolism, cigarette smoking, and breast cancer risk: A Bayes model averaging approach

Epidemiologic Perspectives and Innovations

Volumn 7, Issue 1, 2010, Pages

  Stephenson, Nadine ^a   Beckmann, Lars ^a   Chang Claude, Jenny ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGEN; CYTOCHROME P450 1A1; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE T1; TOBACCO SMOKE;

ARTICLE; BAYES MODEL AVERAGING APPROACH; BREAST CANCER; CANCER RISK; CARCINOGENESIS; CIGARETTE SMOKING; CONTROLLED STUDY; DATA ANALYSIS; ENVIRONMENTAL FACTOR; GENE DELETION; GENETIC VARIABILITY; HUMAN; LOGISTIC REGRESSION ANALYSIS; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

EID: 78650216635     PISSN: None     EISSN: 17425573     Source Type: Journal    
DOI: 10.1186/1742-5573-7-10     Document Type: Article

References (23)

1. Bayesian modeling of complex metabolic pathways. DV Conti V Cortessis J Molitor DC Thomas, Hum Hered 2003 56 83 93 10.1159/000073736 14614242
2. Bayesian perspectives for epidemiological research. II. Regression analysis. S Greenland, Int J Epidemiol 2007 36 195 202 10.1093/ije/dyl289 17329317
3. Differential effect of NAT2 on the association between active and passive smoke exposure and breast cancer risk. J Chang-Claude S Kropp B Jager H Bartsch A Risch, Cancer Epidemiol Biomarkers Prev 2002 11 698 704 12163321
4. The Association between Tobacco Exposure and Breast Cancer Risk considering potentially modifying Effects of specific Genotypes. S Kropp, PhD Thesis University of Heidelberg 2001
5. Active and passive smoking and risk of breast cancer by age 50 years among German women. S Kropp J Chang-Claude, Am J Epidemiol 2002 156 616 626 10.1093/aje/kwf093 12244030
6. Generalized linear models. TJ Hastie D Pregibon, 1992
7. Prior distributions for variance parameters in hierarchical models. A Gelman, Bayesian Analysis 2006 1 515 533 10.1214/06-BA117A
8. WinBUGS version 2.10. DJ Spiegelhalter, 2005
9. Bayes Factors. AE Raftery, J Am Statist Assoc 1995 90 773 795 10.2307/2291091
10. N-acetyltransferase 1 genetic polymorphism, cigarette smoking, well-done meat intake, and breast cancer risk. W Zheng AC Deitz DR Campbell WQ Wen JR Cerhan TA Sellers AR Folsom DW Hein, Cancer Epidemiol Biomarkers Prev 1999 8 233 239 10090301
11. NAT1*10 and NAT1*11 polymorphisms and breast cancer risk. RC Millikan, Cancer Epidemiol Biomarkers Prev 2000 9 217 219 10698485
12. Differences in N-acetylation genotypes between Caucasians and Black South Africans: implications for cancer prevention. A Loktionov W Moore SP Spencer H Vorster T Nell IK O'Neill SA Bingham JH Cummings, Cancer Detect Prev 2002 26 15 22 10.1016/S0361-090X(02)00010-7 12088198
13. Identification and characterization of variant alleles of human acetyltransferase NAT1 with defective function using p-aminosalicylate as an in-vivo and in-vitro probe. NC Hughes SA Janezic KL McQueen MA Jewett T Castranio DA Bell DM Grant, Pharmacogenetics 1998 8 55 66 10.1097/00008571- 199802000-00008 9511182
14. Genotyping human arylamine N-acetyltransferase type 1 (NAT1): the identification of two novel allelic variants. MA Payton E Sim, Biochem Pharmacol 1998 55 361 366 10.1016/S0006-2952(97)00478-4 9484803
15. Correlation between genotype and phenotype of the human arylamine N-acetyltransferase type 1 (NAT1). C Bruhn J Brockmoller I Cascorbi I Roots HH Borchert, Biochem Pharmacol 1999 58 1759 1764 10.1016/S0006-2952(99)00269-5 10571250
16. Relationship between NAT1 genotype and phenotype in a Japanese population. M Yang T Katoh R Delongchamp S Ozawa K Kohshi T Kawamoto, Pharmacogenetics 2000 10 225 232 10.1097/00008571-200004000-00003 10803678
17. Role of aromatic amine acetyltransferases, NAT1 and NAT2, in carcinogen-DNA adduct formation in the human urinary bladder. AF Badawi A Hirvonen DA Bell NP Lang FF Kadlubar, Cancer Res 1995 55 5230 5237 7585581
18. Polyadenylation polymorphism in the acetyltransferase 1 gene (NAT1) increases risk of colorectal cancer. DA Bell EA Stephens T Castranio DM Umbach M Watson M Deakin J Elder C Hendrickse H Duncan RC Strange, Cancer Res 1995 55 3537 3542 7627961
19. Cumulative genetic defects in carcinogen metabolism may increase breast cancer risk (The Netherlands). OL van der Hel HB Bueno-de-Mesquita CH van Gils M Roest B Slothouber DE Grobbee PH Peeters, Cancer Causes Control 2005 16 675 681 10.1007/s10552-005-1227-0 16049806
20. A computer program for power and sample size calculations for genetic-epidemiology studies. (1.2.4). J Gauderman J Morrison QUANTO, 2006
21. Cigarette smoking, N-acetyltransferase 2 genotypes, and breast cancer risk: pooled analysis and meta-analysis. CB Ambrosone S Kropp J Yang S Yao PG Shields J Chang-Claude, Cancer Epidemiol Biomarkers Prev 2008 17 15 26 10.1158/1055-9965.EPI-07-0598 18187392
22. Glutathione S-transferases M1, T1, and P1 and breast cancer: a pooled analysis. FD Vogl E Taioli C Maugard W Zheng LF Pinto C Ambrosone FF Parl V Nedelcheva-Kristensen TR Rebbeck P Brennan, et al. Cancer Epidemiol Biomarkers Prev 2004 13 1473 1479 15342448
23. Is the association between cigarette smoking and breast cancer modified by genotype? A review of epidemiologic studies and meta-analysis. PD Terry M Goodman, Cancer Epidemiol Biomarkers Prev 2006 15 602 611 10.1158/1055-9965.EPI- 05-0853 16614098